Quetiapine for Sleep: Not Recommended as First-Line Treatment

Guideline-Based Recommendations Against Quetiapine for Sleep

The VA/DoD Clinical Practice Guidelines explicitly advise against using antipsychotics, including quetiapine, for chronic insomnia disorder, due to sparse and inconclusive efficacy evidence combined with significant safety risks, including increased mortality in elderly patients with dementia and metabolic complications 1, 2, 3
The American College of Physicians recommends against using quetiapine as first-line treatment for insomnia, even in patients with psychiatric conditions, due to the lack of conclusive efficacy evidence and significant safety concerns 1, 2, 3
No studies met inclusion criteria for quetiapine as an intervention for chronic insomnia disorder, and evidence supporting quetiapine use is sparse and unclear, with small sample sizes and short treatment durations, making efficacy determination inconclusive 1, 2, 3
All antipsychotics, including low-dose quetiapine, cause known harms, including increased risk for death in elderly populations with dementia-related psychosis and increased suicidal tendencies in children, adolescents, and young adults 1, 2, 3

The American Academy of Sleep Medicine recommends benzodiazepine receptor agonists, such as zolpidem, zaleplon, and temazepam, as first-line options for hospitalized patients with sleep disturbances 4
Trazodone 25-100 mg at bedtime is a recommended alternative agent, particularly useful when comorbid depression or anxiety is present 4
Ramelteon is a recommended alternative agent for patients with substance use history, as it is non-DEA scheduled 4

The FDA has labeled quetiapine with adverse effects relevant to sleep use, including somnolence, orthostatic hypotension, metabolic complications, anticholinergic effects, and hyperprolactinemia 1, 2, 3
Quetiapine prescribed as sedative-hypnotic in dementia patients is common but understudied and not without risk, with increased mortality risk in elderly with dementia-related psychosis 1, 2, 3

The Society of Critical Care Medicine recommends against using atypical antipsychotics, including quetiapine, for sleep promotion in ICU patients, due to insufficient information and potential harms 6, 7, 8